Medical News

RSS

Appropriations package approved by House, Senate to consider next

The House on Thursday "took a major step toward wrapping up the FY10 appropriations process when it approved, 221-202, a nearly $450 billion spending package that includes six of the seven annual appropriations bills Congress has yet to enact," CongressDaily reports.

11 Dec 2009

Anti-estrogens may reduce the risk of death from lung cancer, according to study results

Anti-estrogens as therapy for breast cancer may also reduce the risk of death from lung cancer, according to study results presented at the CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 9-13, 2009.

11 Dec 2009

Phase 2 pivotal trial of AC220 initiated by Ambit Biosciences

Ambit Biosciences Corporation announced today the enrollment and dosing at the University of Texas M. D. Anderson Cancer Center of the first patient in the ACE (AC220 Monotherapy Efficacy) Phase 2 pivotal trial in patients with relapsed or refractory acute myeloid leukemia (AML).

11 Dec 2009

About 47M infected, 10,000 dead from H1N1 in U.S., CDC says

U.S. health officials on Thursday announced nearly 10,000 people in the U.S. had died from H1N1 (swine flu) since the virus was first reported in April, the New York Times reports.

11 Dec 2009

Talk To Me Technologies to help customers get funding through Medicare, Medicaid and private insurance

AbleNet, Inc. announces a new program to offer Medicaid, Medicare and private insurance funding support through Talk To Me Technologies, LLC. This service is effective December 2009 for the AbleNet SuperTalker™ progressive communicator and FL4SH™ scanning communicator products.

11 Dec 2009

Preliminary results of WebMD Health's tender offer

WebMD Health Corp. announced today the preliminary results of its tender offer to purchase up to 5,700,000 shares of its common stock at a price of $37.00 per share, which expired at 5:00 p.m., New York City time on December 10, 2009.

11 Dec 2009

HTDS comments on its recent stock price activity

Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.

11 Dec 2009

Zevalin clinical data presented at 2009 ASH meeting

Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

11 Dec 2009

University of the Rockies offers new specialization course in management and counseling

Bridgepoint Education, Inc. , a provider of post-secondary education services focused on providing higher access to higher education, announced today that University of the Rockies, a graduate school specializing in psychology programs at the master's and doctoral levels, has added a new Master of Arts specialization in Career Management and Counseling.

11 Dec 2009

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Seattle Genetics, Inc. today reported that it has been notified by Genentech, a wholly owned member of the Roche Group, that Genentech has elected to terminate the companies’ collaboration agreement for dacetuzumab (SGN-40). Dacetuzumab is a monoclonal antibody targeting CD40 that has been investigated in clinical trials for non-Hodgkin lymphoma and multiple myeloma.

11 Dec 2009

CyMap technology wins first prize in the Medical and Healthcare category

CyMap, an innovative lens-free microscope developed by Cancer Research UK scientists and members of the Optical Biochips Consortium*, has won first prize in the Medical and Healthcare category of The Engineer's Technology and Innovation Awards as well as the overall Grand Prix prize.

11 Dec 2009

First Edition: December 11, 2009

Today's headlines track the fits and starts of the Senate's health bill debate, including moderates' concern regarding the recent Medicare expansion deal and House Speaker Nancy Pelosi's positive reaction to it. Meanwhile, floor action appears snagged on a drug importation amendment.

11 Dec 2009

Prescription drug and healthcare expenditures increase for U.S. adults

In 2006 the average cost for a prescription drug purchase for Americans age 18 to 44 was double the inflation-adjusted average for 1996, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

11 Dec 2009

HHS: Current research efforts and developments in influenza vaccine technologies

The U.S. Department of Health and Human Services (HHS) will host a three-hour educational program for the media to learn more about ongoing government research efforts to develop and apply new technologies in the making of seasonal and pandemic influenza vaccines.

11 Dec 2009

Financial results for second fiscal quarter announced by China Cord Blood

China Cord Blood Corporation ("CCBC" or "the Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its unaudited financial results for the quarter and six months ended September 30, 2009.

11 Dec 2009

"Gift a bed net" initiative to prevent malaria

Along with the joy of the holiday season comes the usual pressure for families. There are cards to send, cookies to bake, and gifts to wrap. However, one thing most American families don't have to worry this Christmas is finding enough money to protect their children from a life-threatening illness. That's not the case for families like Rachell Chuya and her five children in Zambia.

11 Dec 2009

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

LinkMed’s portfolio company Likvor has received an order for Likvor CELDA™ from Uppsala University Hospital (Akademiska Universitetssjukhuset).

11 Dec 2009

Optics Balzers expands its market presence in Europe

Additional important milestones have been reached on the road to success, and the pace continues to be fast. By setting up a sales branch office in France, Optics Balzers as a provider of innovative optical thin-film components and assemblies continues to forge ahead with expanding its presence in Europe.

11 Dec 2009

Pfizer's Prevenar 13 granted European marketing authorization

The European Commission has granted Pfizer Inc. a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age. Invasive pneumococcal disease includes sepsis, meningitis, bacteremia, bacteremic pneumonia, and empyema.

11 Dec 2009

Proteins from catfish venom glands could accelerate wound healing in humans

Lest anyone have concerns about attacks of killer catfish, rest assured that, at least in North America, these finned fatales use their venom mainly to defend themselves against predatory fish, though they can inflict a painful sting that many fishermen have suffered. In other parts of the world, some catfish do have extremely toxic venoms that can be deadly to humans.

11 Dec 2009